Pharmafile Logo

thinkemotive

- PMLiVE

Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis

The inflammatory skin disease affects over 26 million people in the US alone

- PMLiVE

Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division

Arnhofer was most recently senior vice president of customer strategy at BioNTech SE

- PMLiVE

Novo Nordisk to cut US insulin prices by up to 75% in January 2024

The decision comes just weeks after Eli Lilly announced a similar series of price cuts

- PMLiVE

Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children

The companies have also submitted an application to the EMA for this age group

Biogen Idec building

Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration

US veterans in the early stages of the disease who meet VHA criteria will be eligible for coverage

- PMLiVE

Results for Astellas’ non-hormonal menopause drug published in The Lancet

Symptoms such as hot flashes and night sweats are the most common symptoms of menopause

- PMLiVE

Roche’s Polivy backed by FDA Advisory Committee for lymphoma therapy

Around 160,000 people worldwide are estimated to be diagnosed with DLBCL each year

- PMLiVE

GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate

There are currently no licensed vaccines offering simultaneous protection against all five serogroups

- PMLiVE

LEO Pharma enters clinical trial partnership with ICON

The collaboration will focus on advancing clinical trial execution within medical dermatology

- PMLiVE

Wave Healthcare Communications appoints Gareth Tucker as commercial director

Tucker was previously chief executive officer of Obsidian Healthcare Group

- PMLiVE

Medscape Education Demonstrates Deep Cardiology Outcomes Expertise at ACC 2023

As cardiologists from around the world return home from New Orleans and ACC 2023, Medscape Education is looking back at a successful conference.At this year’s event, the Medscape Education team...

Medscape Education

- PMLiVE

Pfizer to acquire Seagen for $43bn in biggest pharma transaction since 2019

The deal includes four approved medicines and Seagen’s antibody-drug conjugate technology

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links